Changes to the gut microbiota drive the progression of cardiometabolic disease

Affiliations

Comment

Gregory B Lim. Nat Rev Cardiol. 2022 May.

. 2022 May;19(5):283.

doi: 10.1038/s41569-022-00686-w.

No abstract available

Comment on

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease.
Talmor-Barkan Y, Bar N, Shaul AA, Shahaf N, Godneva A, Bussi Y, Lotan-Pompan M, Weinberger A, Shechter A, Chezar-Azerrad C, Arow Z, Hammer Y, Chechi K, Forslund SK, Fromentin S, Dumas ME, Ehrlich SD, Pedersen O, Kornowski R, Segal E. Talmor-Barkan Y, et al. Nat Med. 2022 Feb;28(2):295-302. doi: 10.1038/s41591-022-01686-6. Epub 2022 Feb 17. Nat Med. 2022. PMID: 35177859 Free PMC article.

1. Talmor-Barkan, Y. et al. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nat. Med. 28, 295–302 (2022) - DOI
1. Fromentin, S. et al. Microbiome and metabolome features of the cardiometabolic disease spectrum. Nat. Med. 28, 303–314 (2022) - DOI

1. Tang, W. H. W. et al. Dietary metabolism, the gut microbiome, and heart failure. Nat. Rev. Cardiol. 16, 137–154 (2019) - DOI